Executive summary: The post argues that cluster headaches involve extreme, poorly measured suffering that is underprioritized by current health metrics, and that psychedelics—especially vaporized DMT—can abort attacks near-instantly, motivating a push for legal access via the ClusterFree initiative.
Key points:
Cluster headaches cause intense unilateral pain lasting 15 minutes to 3 hours, recurring multiple times per day over weeks, and are often rated as “10” on the 0–10 Numeric Rating Scale by patients.
Standard pain scales and QALY metrics compress extreme suffering, which the author argues leads to systematic underfunding of conditions like cluster headaches.
The author claims pain reports follow a logarithmic pattern consistent with Weber’s law, implying that differences near the top of pain scales represent orders-of-magnitude changes in experience.
Survey evidence summarized by the author suggests psilocybin is more effective than oxygen or triptans for aborting attacks, and emerging evidence suggests vaporized DMT is faster and more effective still.
DMT can be effective at “sub-psychedelic” doses, acts within seconds when inhaled, has a short half-life, and does not appear to produce tolerance according to patient reports cited.
ClusterFree, a Qualia Research Institute initiative, aims to expand legal access to psychedelics for cluster headache patients through research, policy advocacy, and public letters.
This comment was auto-generated by the EA Forum Team. Feel free to point out issues with this summary by replying to the comment, andcontact us if you have feedback.
Executive summary: The post argues that cluster headaches involve extreme, poorly measured suffering that is underprioritized by current health metrics, and that psychedelics—especially vaporized DMT—can abort attacks near-instantly, motivating a push for legal access via the ClusterFree initiative.
Key points:
Cluster headaches cause intense unilateral pain lasting 15 minutes to 3 hours, recurring multiple times per day over weeks, and are often rated as “10” on the 0–10 Numeric Rating Scale by patients.
Standard pain scales and QALY metrics compress extreme suffering, which the author argues leads to systematic underfunding of conditions like cluster headaches.
The author claims pain reports follow a logarithmic pattern consistent with Weber’s law, implying that differences near the top of pain scales represent orders-of-magnitude changes in experience.
Survey evidence summarized by the author suggests psilocybin is more effective than oxygen or triptans for aborting attacks, and emerging evidence suggests vaporized DMT is faster and more effective still.
DMT can be effective at “sub-psychedelic” doses, acts within seconds when inhaled, has a short half-life, and does not appear to produce tolerance according to patient reports cited.
ClusterFree, a Qualia Research Institute initiative, aims to expand legal access to psychedelics for cluster headache patients through research, policy advocacy, and public letters.
This comment was auto-generated by the EA Forum Team. Feel free to point out issues with this summary by replying to the comment, and contact us if you have feedback.